GlaxoSmithKline Plc Valuation
| GSKN Stock | MXN 655.00 51.98 7.35% |
At this time, the firm appears to be fairly valued. GlaxoSmithKline plc retains a regular Real Value of 668.0 per share. The prevalent price of the firm is 655.0. Our model calculates the value of GlaxoSmithKline plc from evaluating the firm fundamentals such as return on equity of 0.31, and Return On Asset of 0.0659 as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors encourage acquiring undervalued assets and dropping overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Fairly Valued
Today
Please note that GlaxoSmithKline Plc's price fluctuation is very steady at this time. Calculation of the real value of GlaxoSmithKline plc is based on 3 months time horizon. Increasing GlaxoSmithKline Plc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for GlaxoSmithKline plc is useful when determining the fair value of the GlaxoSmithKline stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of GlaxoSmithKline Plc. Since GlaxoSmithKline Plc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GlaxoSmithKline Stock. However, GlaxoSmithKline Plc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 655.0 | Real 668.0 | Hype 655.0 | Naive 629.85 |
The real value of GlaxoSmithKline Stock, also known as its intrinsic value, is the underlying worth of GlaxoSmithKline plc Company, which is reflected in its stock price. It is based on GlaxoSmithKline Plc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of GlaxoSmithKline Plc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GlaxoSmithKline Plc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GlaxoSmithKline plc helps investors to forecast how GlaxoSmithKline stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GlaxoSmithKline Plc more accurately as focusing exclusively on GlaxoSmithKline Plc's fundamentals will not take into account other important factors: GlaxoSmithKline Plc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining GlaxoSmithKline Plc's current stock value. Our valuation model uses many indicators to compare GlaxoSmithKline Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GlaxoSmithKline Plc competition to find correlations between indicators driving GlaxoSmithKline Plc's intrinsic value. More Info.GlaxoSmithKline plc is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies fabricating about 0.53 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for GlaxoSmithKline plc is roughly 1.87 . Comparative valuation analysis is a catch-all model that can be used if you cannot value GlaxoSmithKline Plc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GlaxoSmithKline Plc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GlaxoSmithKline Plc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates GlaxoSmithKline Plc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in GlaxoSmithKline Plc and how it compares across the competition.
About GlaxoSmithKline Plc Valuation
The stock valuation mechanism determines the current worth of GlaxoSmithKline plc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of GlaxoSmithKline plc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of GlaxoSmithKline plc based exclusively on its fundamental and basic technical indicators. By analyzing GlaxoSmithKline Plc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of GlaxoSmithKline Plc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of GlaxoSmithKline Plc. We calculate exposure to GlaxoSmithKline Plc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to GlaxoSmithKline Plc's related companies.GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GLAXOSMITHKLINE is traded on Mexico Stock Exchange in Mexico.
8 Steps to conduct GlaxoSmithKline Plc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates GlaxoSmithKline Plc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct GlaxoSmithKline Plc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain GlaxoSmithKline Plc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine GlaxoSmithKline Plc's revenue streams: Identify GlaxoSmithKline Plc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research GlaxoSmithKline Plc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish GlaxoSmithKline Plc's growth potential: Evaluate GlaxoSmithKline Plc's management, business model, and growth potential.
- Determine GlaxoSmithKline Plc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate GlaxoSmithKline Plc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlaxoSmithKline plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline Plc's price analysis, check to measure GlaxoSmithKline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline Plc is operating at the current time. Most of GlaxoSmithKline Plc's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline Plc's price. Additionally, you may evaluate how the addition of GlaxoSmithKline Plc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |